Table 3.
Global quality of life assessed by the EORTC QLQ-C30 and the EORTC QLQ-BR23
| N = 45 | |||
|---|---|---|---|
| N | Mean | SD | |
| EORTC QLQ-C30 | |||
| Functional scales | |||
| Global health status | 45 | 69.63 | 17.60 |
| Physical functioning | 45 | 87.85 | 12.89 |
| Role functioning | 45 | 82.22 | 24.46 |
| Emotional functioning | 45 | 55.37 | 32.18 |
| Cognitive functioning | 45 | 59.26 | 31.89 |
| Social functioning | 45 | 80.37 | 23.65 |
| Symptom scales | |||
| Fatigue | 45 | 41.48 | 27.67 |
| Nausea and vomiting | 45 | 4.07 | 9.51 |
| Pain | 45 | 27.04 | 29.15 |
| Dyspnea | 45 | 22.96 | 24.44 |
| Insomnia | 45 | 46.67 | 43.46 |
| Appetite loss | 45 | 7.41 | 21.19 |
| Constipation | 45 | 11.85 | 22.65 |
| Diarrhea | 45 | 8.89 | 16.51 |
| Financial difficulties | 45 | 13.33 | 31.30 |
| EORTC QLQ-BR23 | |||
| Functional scales | |||
| Body image | 45 | 66.30 | 30.25 |
| Sexual functioning | 45 | 35.19 | 24.68 |
| Sexual enjoyment | 34 | 62.75 | 28.15 |
| Future Perspective | 45 | 40.74 | 31.69 |
| Symptom scales | |||
| Systemic therapy side effects | 45 | 26.56 | 17.69 |
| Breast symptoms | 44 | 22.73 | 18.97 |
| Arm symptoms | 44 | 22.73 | 23.96 |
| Upset by hair loss | 0 | ||
N, number of women who answered the question